EU Medicines Agency Recommends Boost in Manufacturing Capacity for Covid Vaccines
April 23 2021 - 9:46AM
Dow Jones News
By Cecilia Butini
The European Medicines Agency said Friday that its human
medicines committee has adopted recommendations to increase
manufacturing capacity and supply of Covid-19 vaccines in the
European Union.
The agency said it has approved an increase in batch size and
process scale-up at Pfizer Inc.'s manufacturing site in Puurs,
Belgium, a move which is expected to have a "significant" impact on
the supply of the vaccine it developed with BioNTech SE.
The agency's committee for medicinal products for human use also
recommended the approval of a new filling line at Moderna Inc.'s
manufacturing site in Rovi, Spain, the EMA said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 23, 2021 09:31 ET (13:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024
